FIELD: biotechnology.
SUBSTANCE: invention relates to the use of biologically active compounds of natural origin — the class of hydrolyzable tannins, namely the use of 4-O-α-L-arabinofuranosylellagic acid of formula (1) as an agent having antiaggregation activity.
EFFECT: effective antiaggregation activity of 4-O-α -L-arabinofuranosylellagic acid, which can find its use in pharmacology and medicine as an antiaggregation drug.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF 1-(3,5-DIHYDROXY-4-METHOXYPHENYL)-2-(3-HYDROXYPHENYL)-ETHANE WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2806331C1 |
| USE OF 2,3,4-TRIMETHOXY-5-HYDROXY-9,10-DIHYDROPHENANTHRENE AS AN AGENT WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2808460C1 |
| USE OF 5,7-DIHYDROXY-6,8-DIMETHYLFLAVANONE AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2812630C1 |
| AGENT WITH ANTIAGGREGATORY ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2778686C1 |
| AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
| 2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
| N'-PYRIDIN-4-YLMETHYLENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTIAGGREGATION AND ANTICOAGULANT ACTIVITY | 2024 |
|
RU2825129C1 |
| 2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
| TRIAZOLE DERIVATIVES EXHIBITING ANTIAGGREGATORY ACTIVITY | 2021 |
|
RU2770405C1 |
| METHOD OF PRODUCING ANTIAGGREGATORY AND ANTIOXIDANT AGENT | 2023 |
|
RU2819387C1 |
